Related references
Note: Only part of the references are listed.Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients
L. Wang et al.
JOURNAL OF VIRAL HEPATITIS (2010)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine
Mariko Kobayashi et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Genotyping Hepatitis B virus from whole- and sub-genomic fragments using position-specific scoring matrices in HBVSTAR
Richard Myers et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China
G Zeng et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B
JW Shin et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B
SK Fung et al.
JOURNAL OF VIRAL HEPATITIS (2004)
A web-based genotyping resource for viral sequences
M Rozanov et al.
NUCLEIC ACIDS RESEARCH (2004)
Four years of lamivudine treatment in Chinese patients with chronic hepatitis B
TT Chang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Determinants for sustained HBeAg response to lamivudine therapy
RN Chien et al.
HEPATOLOGY (2003)
Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study
SH Ryu et al.
JOURNAL OF HEPATOLOGY (2003)
Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in Taiwan
YH Huang et al.
JOURNAL OF VIRAL HEPATITIS (2003)
Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders
ER Schiff et al.
JOURNAL OF HEPATOLOGY (2003)
Quantitative polymerase chain reaction assay for serum hepatitis B virus DNA as a predictive factor for post-treatment relapse after lamivudine induced hepatitis B e antigen loss or seroconversion
HC Lee et al.
GUT (2003)
Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea
BC Song et al.
HEPATOLOGY (2000)
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
FY Yao et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
